Skip to content
★ Sign in to follow
TJ

Thomas James Flanagan

Total declarations
22
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€495k

Latest filing published 09 Dec 2010 for AMGEN INC, €30k.

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

No signal scores available.

Thomas James Flanagan: trading record in brief

Thomas James Flanagan discloses dealings in Amgen Inc to SEC (Form 4). In total, 22 filings cover trades dated from 31 July 2007 to 8 December 2010.

No open-market purchase appears, only 7 sales worth €495k. Outside the open market, there are 14 share grants. So far in 2010, the count stands at no purchases and 1 sale.

The latest filing, published on 9 December 2010, reports an open-market sale of €30k in Amgen Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Thomas James Flanagan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations